THE THYMUS AND PROLONGED ADMINISTRATION OF CYCLOSPORINE
- 1 July 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 50 (1) , 106-111
- https://doi.org/10.1097/00007890-199007000-00020
Abstract
Previous studies have demonstrated that short-term administration of cyclosporine leads to immunopathologic changes in the thymus, including medullary involution, loss of Hassall''s corpuscles, and decreased class II antigen expression. Generally these changes are rapidly reversible. In rats treated with mediastinal irradiation, however, these changes are irreversible and usually associated with autologous or syngeneic graft-vs.-host disease (pseudo-GVHD). This study describes the immunopathology of the thymus after long-term administration of CsA (7 mg/kg/day, up to 140 days) and monitors the recovery post-CsA. The medulla was markedly involuted at the end of CsA, regardless of duration. The relative size of the medulla showed good recovery. Long-term CsA, however, profoundly delayed or prevented the recovery, profoundly delayed or prevented the recovery of Hassall''s corpuscles and normal expression of class II antigen. The epithelial cells in Hassall''s corpuscles totally disappeared at the end of CsA administration. Following 7 or 28 days of CsA, the Hassall''s corpuscles recovered within one month. After 70 days CsA, recovery was delayed until the second month, while after 140 days, Hassall''s corpuscles were not present even 2 months post-CsA. Class II antigen was decreased in the subcapsular and juxtamedullary regions at 140 days as well as 1 and 2 months post-CsA. Paralleling the thymic immunopathology, acute and chronic pseudo-GVHD were observed in the skin, tongue, liver, intestines, lacrimal glands bronchi and intestines following long-term CsA.This publication has 23 references indexed in Scilit:
- Phenotypic analysis of thymocytes that express homing receptors for peripheral lymph nodes.The Journal of Immunology, 1986
- Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.The Journal of Experimental Medicine, 1985
- Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.The Journal of Experimental Medicine, 1983
- Thymic medullary lymphocytesCellular Immunology, 1982
- Two subsets of rat T lymphocytes defined with monoclonal antibodiesEuropean Journal of Immunology, 1980
- Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.The Journal of Immunology, 1980
- Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.The Journal of Immunology, 1980
- PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN AThe Lancet, 1978
- EXTENSIVE PROLONGATION OF RABBIT KIDNEY ALLOGRAFT SURVIVAL AFTER SHORT-TERM CYCLOSPORIN-A TREATMENTThe Lancet, 1978
- Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytesCell, 1977